Report : North America Bioactive Wound Management Market to 2027- Covid-19 Impact and Regional Analysis by Product (Bioengineered Skin Substitutes, Collagen-based Dressing, Antimicrobial Dressings, Alginates, and Hydrocolloids) ; Application (Pressure Ulcers, Diabetic Foot Ulcers, Venous Leg Ulcers, Burn Wounds, and Surgical Wounds); End User ([Hospitals and Clinics, Ambulatory Surgical Centers, and Others)], and Country
Alginates Segment Held Largest Share of North America Bioactive Wound Management Market in 2019
According to our new market research study on “North America Bioactive wound management Market to 2027 – Regional Analysis and Forecast – by Product, Application,and End User,”the market is expected to reach US$ 1,333.21 millionby 2027 from US$ 755.37 million in 2019; it is estimated to grow at a CAGR of 7.4% from 2020 to 2027. The report provides trends prevailing in the North Americabioactive wound management market and the factors driving the market growth along with those hindering it.
Based on product, the North Americabioactive wound management market is segmented into alginates, collagen-based dressing, antimicrobial dressings, bioengineered skin substitutes, and hydrocolloids.The alginates segment held the largest share of the market in 2019. The growth of the alginates segment is attributed to the increasing need for efficient and cost-effective wound management. Furthermore, the dominance of the segment is further attributed to a wide range of products available in the market and increasing adoption of bioactive treatment of chronic wounds. However, the bioengineered skin substitutes segment is expected to grow with the highest growth rate during the forecast period, owing to its acceptance in a wide range of chronic wounds due to its faster healing and reduced infection properties.
The growth of the North Americabioactive wound management marketis mainly attributed to the increasing incidences of wounds and ulcers, growing number of surgical procedures, and innovation in advanced wound care products. However,high cost associated with superior quality wound care management and lack of reimbursement policiesare the major factor hindering the market growth in North America.
Covalon Technologies Ltd., Integra Life Sciences Corporation, Organogenesis Inc.,MiMedx,and ETS Wound Care, LLC. are some of the leading companies operating in the North Americabioactive wound management market.
The report segments North America bioactive wound management marketas follows:
North America Bioactive Wound Management Market– ByProduct
North America Bioactive Wound Management Market – ByApplication
North America Bioactive Wound Management Market – By End-users
North America Bioactive Wound Management Market– By Country
Contact Person: Sameer Joshi
Email Id: email@example.com